Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | PRNP | P04156 | 1/20 | 0.30 |
| ▸ | TACR1 | P25103 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20113732 | 0.94 | L3MBTL1 (0.39) | L3MBTL1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL20109174 | 0.83 | ALDH1A1 (0.34) | L3MBTL1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL20109200 | 0.82 | MMP8 (0.41) | L3MBTL1ALDH1A1MAPK1TDP1HPGD | |
| SCHEMBL20113900 | 0.79 | MMP8 (0.53) | L3MBTL1ALDH1A1TDP1LMNATP53 | |
| SCHEMBL20113729 | 0.77 | EPHX2 (0.41) | ALDH1A1TDP1CYP3A4HPGDLMNA | |
| SCHEMBL20113733 | 0.77 | PPARG (0.41) | ALDH1A1MAPK1HPGDLMNATP53 | |
| SCHEMBL20109148 | 0.77 | MMP8 (0.37) | L3MBTL1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL20113397 | 0.76 | ALDH1A1 (0.39) | L3MBTL1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL20113726 | 0.75 | PPARG (0.44) | ALDH1A1MMP8KMT2AMEN1 | |
| SCHEMBL20109220 | 0.74 | MMP8 (0.36) | L3MBTL1ALDH1A1MAPK1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118770-A1 | N-Heterocyclic Phosphines | NANP, PPIP5K2, PHPT1 | L3MBTL1 3799/4885ALDH1A1 4621/4885MAPK1 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.